1. Mucin 1-mediated chemo-resistance in lung cancer cells
   S Y Ham et al, 2016, Oncogenesis CrossRef
2. A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer
   Mayuri Narvekar et al, 2014, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
3. The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium
   Gang Ning et al, 2014, J. Pathol. CrossRef
4. A uniform 2,5-dihydroxybenzoic acid layer as a matrix for MALDI-FTICR MS-based lipidomics
   Yanbo Wei et al, 2015, Analyst CrossRef
5. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties
   Chang-Ryul Lee et al, 2016, CARCIN CrossRef
6. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism
   Eun Jin Seo et al, 2016, Stem Cells CrossRef
7. Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497.
   Lin Liu et al, 0 CrossRef
8. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
   Chongyuan Zhang et al, 2017, Med Sci Monit CrossRef
9. Cytotoxic Effects of Strawberry, Korean Raspberry, and Mulberry Extracts on Human Ovarian Cancer A2780 Cells
   Dahae Lee et al, 2016, JFN CrossRef
10. Jumonji domain‐containing protein 6 protein and its role in cancer
    Jing Yang et al, 2020, Cell Prolif CrossRef
11. H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
    Nan Han et al, 2020, IJMS CrossRef
12. New tri- and di-alkylstannyl 2-(1H-indol-3-yl)ethanoates: synthesis, characterization and biological screenings
    Farzana Shaheen et al, 2020, Journal of Coordination Chemistry CrossRef
13. Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential
    Jing Ma et al, 2018, Oncotarget CrossRef
14. Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells
    Sham S. Kakar et al, 2017, Oncotarget CrossRef
15. Expression of integrin α‑6 is associated with multi drug resistance and prognosis in ovarian cancer
    Luwei Wei et al, 2019, Oncol Lett CrossRef
16. Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells
    Md. Hafiz Uddin et al, 2020, Heliyon CrossRef
17. Nanog-mediated stem cell properties are critical for MBNL3-associated paclitaxel resistance of ovarian cancer
    Xueqin Sun et al, 2021 CrossRef
18. Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model
    Marta Nowacka et al, 2022, IJMS CrossRef
19. Dysregulated FOXM1 Signaling in the regulation of cancer stem cells
    Gulab Sher et al, 2022, Seminars in Cancer Biology CrossRef